Alcalá L - Search Results

1

Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact.

Galar A, Valerio M, Muñoz P, Alcalá L, García-González X, Burillo A, Sanjurjo M, Grau S, Bouza E. Galar A, et al. Among authors: alcala l. Antimicrob Agents Chemother. 2017 Sep 22;61(10):e00687-17. doi: 10.1128/AAC.00687-17. Print 2017 Oct. Antimicrob Agents Chemother. 2017. PMID: 28739788 Free PMC article.

2

[Current status of resistance of Staphylococcus in Spain. 4th National Study (1996). Work Group on the Study of Staphylococcus].

Cercenado E, Sánchez-Carrillo C, Alcalá L, Bouza E. Cercenado E, et al. Among authors: alcala l. Rev Clin Esp. 1997 Sep;197 Suppl 2:12-8. Rev Clin Esp. 1997. PMID: 9441317 Spanish. No abstract available.

3

Comparison of broth microdilution method using Haemophilus test medium and agar dilution method for susceptibility testing of Eikenella corrodens.

Alcalá L, García-Garrote F, Cercenado E, Peláez T, Ramos G, Bouza E. Alcalá L, et al. J Clin Microbiol. 1998 Aug;36(8):2386-8. doi: 10.1128/JCM.36.8.2386-2388.1998. J Clin Microbiol. 1998. PMID: 9666033 Free PMC article.

4

In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates.

García-Garrote F, Cercenado E, Alcalá L, Bouza E. García-Garrote F, et al. Among authors: alcala l. Antimicrob Agents Chemother. 1998 Sep;42(9):2452-5. doi: 10.1128/AAC.42.9.2452. Antimicrob Agents Chemother. 1998. PMID: 9736584 Free PMC article.

5

Primary meningococcal conjunctivitis in a human immunodeficiency virus-infected adult.

García-Lechuz JM, Alcalá L, Gijón P, San Juan R, Bouza E. García-Lechuz JM, et al. Among authors: alcala l. Clin Infect Dis. 1998 Dec;27(6):1556-7. doi: 10.1086/517756. Clin Infect Dis. 1998. PMID: 9868694 No abstract available.

6

In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolates.

Alcalá L, Cercenado E, García-Garrote F, Bouza E. Alcalá L, et al. Diagn Microbiol Infect Dis. 1999 Jan;33(1):27-31. doi: 10.1016/s0732-8893(98)00129-1. Diagn Microbiol Infect Dis. 1999. PMID: 9990472

7

Austrian syndrome caused by highly penicillin-resistant Streptococcus pneumoniae.

Muñoz P, Sainz J, Rodríguez-Creixéms M, Santos J, Alcalá L, Bouza E. Muñoz P, et al. Among authors: alcala l. Clin Infect Dis. 1999 Dec;29(6):1591-2. doi: 10.1086/313542. Clin Infect Dis. 1999. PMID: 10585831 Review. No abstract available.

8

In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs.

Ruiz-Serrano MJ, Alcalá L, Martínez L, Díaz M, Marín M, González-Abad MJ, Bouza E. Ruiz-Serrano MJ, et al. Among authors: alcala l. Antimicrob Agents Chemother. 2000 Sep;44(9):2567-8. doi: 10.1128/AAC.44.9.2567-2568.2000. Antimicrob Agents Chemother. 2000. PMID: 10952620 Free PMC article.

9

Utility of the BACTEC Myco/F lytic medium for the detection of mycobacteria in blood.

Martínez-Sánchez L, Ruiz-Serrano J, Bouza E, Torres L, Díaz M, Alcalá L, Rodríguez-Créixems M. Martínez-Sánchez L, et al. Among authors: alcala l. Diagn Microbiol Infect Dis. 2000 Dec;38(4):223-6. doi: 10.1016/s0732-8893(00)00202-9. Diagn Microbiol Infect Dis. 2000. PMID: 11146247

10

In vitro activity of new quinolones against Clostridium difficile.

Alonso R, Peláez T, González-Abad MJ, Alcalá L, Muñoz P, Rodríguez-Créixems M, Bouza E. Alonso R, et al. Among authors: alcala l. J Antimicrob Chemother. 2001 Feb;47(2):195-7. doi: 10.1093/jac/47.2.195. J Antimicrob Chemother. 2001. PMID: 11157906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters